ASX - Delayed Quote • AUD Cleo Diagnostics Ltd (COV.AX) Follow Compare 0.3450 -0.0050 (-1.43%) At close: January 17 at 3:58:10 PM GMT+11 All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations December 2024 ASX Penny Stocks To Consider As the Australian market navigates a challenging December, with the ASX200 recently dipping below 8,300 points and materials taking a hit, investors are keenly watching for opportunities amidst fluctuating indices. In this climate, penny stocks—though an outdated term—remain relevant as they spotlight smaller or less-established companies that may offer value. By focusing on those with strong financials and growth potential, investors might discover promising opportunities in this... Discover ASX Penny Stocks To Watch In November 2024 The Australian market has experienced a slight downturn, with the ASX200 down 0.4% and all sectors losing ground, as the Reserve Bank keeps rates steady at 4.35%. In such fluctuating conditions, investors often seek opportunities in smaller or newer companies that may offer potential value despite their size. Penny stocks, while an older term, still represent these intriguing investment possibilities; they can provide surprising stability and growth when backed by strong financials and clear... We Think Cleo Diagnostics (ASX:COV) Can Afford To Drive Business Growth Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and... Performance Overview Trailing total returns as of 1/17/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] Return COV.AX S&P/ASX 200 [XJO] YTD -2.82% +1.85% 1-Year +109.09% +12.41% 3-Year +50.00% +12.04%